Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. (Q48352454)

10 February 2018

title

Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. (English)

1 reference

10 February 2018

1 reference

2

1 reference

10 February 2018

Dario Arnaldi

3

1 reference

10 February 2018

Fabrizio De Carli

4

1 reference

10 February 2018

Gianmario Sambuceti

9

1 reference

10 February 2018

Flavio Nobili

object named as

Flavio Nobili

1

0 references

Andrea Brugnolo

6

object named as

Andrea Brugnolo

1 reference

10 February 2018

Barbara Dessi

7

object named as

Barbara Dessi

1 reference

10 February 2018

author name string

Gaia Cabassi

5

1 reference

10 February 2018

Silvia Morbelli

8

1 reference

10 February 2018

Giovanni Abbruzzese

10

1 reference

10 February 2018

Guido Rodriguez

11

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 2010

1 reference

10 February 2018

published in

Movement Disorders

1 reference

10 February 2018

volume

25

1 reference

10 February 2018

page(s)

35-43

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

What causes mental dysfunction in Parkinson's disease?

cites work

1 reference

Dementia associated with Parkinson's disease

21 January 2018

1 reference

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

21 January 2018

1 reference

Molecular imaging of the dopaminergic system and its association with human cognitive function

21 January 2018

1 reference

Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease.

21 January 2018

1 reference

Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy

21 January 2018

1 reference

Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits

21 January 2018

1 reference

Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease.

21 January 2018

1 reference

Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123iodine-beta-CIT in patients on and off levodopa

21 January 2018

1 reference

Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.

21 January 2018

1 reference

Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies

21 January 2018

1 reference

Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus

21 January 2018

1 reference

The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation.

21 January 2018

1 reference

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

Distinguishing normal and demented elderly with the selective reminding test.

21 January 2018

1 reference

Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children

21 January 2018

1 reference

Clinical practice. Essential tremor

21 January 2018

1 reference

Striatal dopamine transporter abnormalities in patients with essential tremor

21 January 2018

1 reference

Accelerated image reconstruction using ordered subsets of projection data

21 January 2018

1 reference

Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.

21 January 2018

1 reference

Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.

21 January 2018

1 reference

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

21 January 2018

1 reference

Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers

21 January 2018

1 reference

Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing

21 January 2018

1 reference

Regional cerebral blood flow in Parkinson's disease with and without dementia.

21 January 2018

1 reference

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

21 January 2018

1 reference

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.

21 January 2018

1 reference

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

21 January 2018

1 reference

Cognitive dysfunction and dementia in Parkinson disease

21 January 2018

1 reference

Neuropsychological prediction of dementia in Parkinson's disease

21 January 2018

1 reference

Corsi Block-Tapping task performance as a function of path configuration.

21 January 2018

1 reference

Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.

21 January 2018

1 reference

The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22899

1 reference

10 February 2018

PubMed ID

20058228

1 reference

10 February 2018